Advertisement

Topics

Search Results for "Micrus Endovascular Merger"

16:33 EDT 27th August 2016 | BioPortfolio

Matching Channels

Jobs in Endovascular

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Boston Scientific

Boston Scientific is a global medical device company, the 8th largest (based on annual sales, which were over $8 billion in 2010). It is the world's second largest maker of heart devices; prod...

Matching News

MR CLEAN at 2 Years: Sustained Endovascular Benefit in Stroke

The first long-term results from the new crop of endovascular trials in stroke show consistent benefit on functional outcomes and suggest a reduction in mortality. Medscape Medical News

Trial begins for Intact Vascular's endovascular system

A 200-patient, multisite clinical trial has been launched by Wayne, Pa.-based Intact Vascular to assess its Tack endovascular -More- 

Pfizer, Allergan Reportedly End Merger Deal

Pfizer is planning to terminate its $152 billion merger with Allergan, after the U.S. Treasury Department proposed new tax regulations that would reduce the proposed merger’s advantages, the New Yor...

New Training Guidelines for Endovascular Stroke Therapy

New international guidelines have been drafted setting out minimum training requirements for physicians performing endovascular thrombectomy procedures for acute stroke patients. Medscape Medical N...

Merger mania

Ebb & Flow Merger mania The unraveling of the merger between Pfizer Inc. (NYSE:PFE) and Allergan plc (NYSE:AGN) has some generalist investors betting bid prices will get more competitive as the two gi...

Endovascular Trials Analysis Confirms Benefit Across Groups

A new patient-level meta-analysis of the first five of the latest positive trials of endovascular treatment in acute stroke has suggested benefit in several key subgroups and up to 8 hours after sympt...

Baxalta Announces Shareholder Approval For Merger Deal With Shire

SAINT HELIER (dpa-AFX) - Baxalta Inc. (BXLT) announced its shareholders approved the definitive merger agreement with Shire plc (SHPG, SHP.L), dated as of January 11, 2016, and the merger transact...

Article Selection and Possible Risk of Bias—Reply

In Reply Dr Elgendy and colleagues suggest that the SYNTHESIS trial should have been excluded from our meta-analysis because the endovascular therapy group did not receive intravenous tPA. At the time...

Matching PubMed Articles

Expanding Endovascular Therapy of Very Small Ruptured Aneurysms with the 1.5-mm Coil.

Very small ruptured aneurysms (≤3 mm) demonstrate a significant risk for procedural rupture with endovascular therapy. Since 2007, 1.5-mm-diameter coils have been available (Micrus, Microvention, an...

Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis.

Endovascular intervention for acute ischemic stroke improves revascularization. But trials examining endovascular therapy yielded variable functional outcomes, and the effect of endovascular intervent...

Thinking Out of the Box to Increase Technical Success in Fenestrated and Branched Endovascular Aneurysm Repair.

Treatment of Type IIIb Endoleaks After EVAR Using the Nellix EndoVascular Aneurysm Sealing System.

To describe the successful endovascular treatment of 2 patients with type IIIb endoleak using the Nellix EndoVascular Aneurysm Sealing (EVAS) System.

A 15-Year Single-Center Experience of Endovascular Repair for Elective and Ruptured Abdominal Aortic Aneurysms.

To evaluate the differences in technical outcomes and secondary interventions between elective endovascular aneurysm repair (el-EVAR) procedures and those for ruptured aneurysms (r-EVAR).

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement